financetom
Business
financetom
/
Business
/
BRIEF-2Seventy Bio Enters Into Agreement To Be Acquired By Bristol Myers Squibb at $5.00 Per Share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-2Seventy Bio Enters Into Agreement To Be Acquired By Bristol Myers Squibb at $5.00 Per Share
Mar 10, 2025 7:47 PM

March 10 (Reuters) - 2Seventy Bio Inc ( TSVT ):

* 2SEVENTY BIO ENTERS INTO DEFINITIVE AGREEMENT TO BE

ACQUIRED BY

BRISTOL MYERS SQUIBB

* 2SEVENTY BIO INC ( TSVT ) - DEAL VALUED AT $5.00 PER SHARE,

ALL-CASH

TRANSACTION

* 2SEVENTY BIO INC ( TSVT ) - TOTAL EQUITY VALUE OF APPROXIMATELY

$286

MILLION

* 2SEVENTY BIO INC ( TSVT ) - DEAL REPRESENTS 88% PREMIUM TO CLOSING

PRICE

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved